Medical Communications

Business chief Jonathan Symonds has joined British multinational GlaxoSmithKline as the company’s new non-executive chairman. The hire ends GSK’s six …

Chief Executive Mike Thompson is to retire from his role at the Association of the British Pharmaceutical Industry (ABPI) by …

Massachusetts-based biotech Disarm Therapeutics has hired Dr Alvin Shih as their new President and CEO. The Cambridge, Mass.-based firm has …

The world needs cheap generic drugs and Indian manufacturers offer a steady supply. However the quality of generics has been …

A report from the Home Office of the UK Government has revealed that the prevalence of animal testing in the …

On 12 July news broke that Novartis, Amgen and Banner’s Alzheimer’s Institute were discontinuing a trial into investigational compound CNP520 …

Novartis has revealed that its disease modifying drug Gilenya (fingolimod) has secured approval in China for the treatment of relapsing …

The Democratic Republic of Congo (DRC) has said it will stick with Merck’s rVSV-ZEBOV ebola vaccine, as it ruled out …

The Royal Pharmaceutical Society (RPS) in Scotland has raised concerns that the Government’s contingency plans do not eliminate the risks …

Gilead has said that Dr John McHutchison is stepping down after nine years at the firm. Gilead’s Chief Scientific Officer …

The release of Women Count 2019, an annual report funded by The Pipeline, has revealed that “little to no progress” …

The World Health Organization (WHO) has said the Ebola outbreak in the Democratic Republic of Congo (DRC) is a global …

The Louvre taken down references to the Sacklers, the billionaire owners of Purdue Pharma. The largest art gallery in the …

Novartis’ Kisqali (ribociclib) has secured recommendation from NICE in combination with fulvestrant, meaning the cyclin-dependent kinase 4 and 6 (CDK4/6) …

“Vaccines provide a unique opportunity to have a positive effect on hundreds of thousands of people” – Darius Hughes, Head …